Detecting adenosine triphosphate in the pericellular space

Interface Focus

Volumn 3, Issue 3, 2013, Pages

  Falzoni, Simonetta ^a   Donvito, Giovanna ^a   Di Virgilio, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Bioluminescence; Cancer; Extracellular adenosine triphosphate; Inflammation; Luciferase

Indexed keywords

EID: 84876558170     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2012.0101     Document Type: Review

References (57)

1. Burnstock G. 2007 Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87, 659-797. (doi:10.1152/physrev.00043.2006)
2. Ralevic V, Burnstock G. 1998 Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492.
3. North RA. 2002 Molecular physiology of P2X receptors. Physiol. Rev. 82, 1013-1067.
4. Fredholm BB. 2010 Adenosine receptors as drug targets. Exp. Cell Res. 316, 1284-1288. (doi:10. 1016/j.yexcr.2010.02.004)
5. Erlinge D. 2011 P2Y receptors in health and disease. Adv. Pharmacol. 61, 417-439. (doi:10.1016/B978-0-12-385526-8.00013-8)
6. Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS. 2011 Activation and regulation of purinergic P2X receptor channels. Pharmacol. Rev. 63, 641-683. (doi:10.1124/pr.110.003129)
7. Bours MJ, Dagnelie PC, Giuliani AL, Wesselius A, Di Virgilio F. 2011 P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front. Biosci. (Schol. Ed.) 3, 1443-1456. (doi:10.2741/235)
8. Burnstock G. 2006 Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 58, 58-86. (doi:10.1124/pr.58.1.5)
9. Rayah A, Kanellopoulos J, Di Virgilio F. 2012 P2 receptors and immunity. Microbes Infect. 14, 1254-1262. (doi:10.1016/j.micinf.2012.07.006)
10. Colgan SP, Eltzschig HK. 2012 Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu. Rev. Physiol. 74, 153-175. (doi:10.1146/annurev-physiol-020911-153230)
11. Yegutkin GG. 2008 Nucleotide-and nucleosideconverting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783, 673-694. (doi:10.1016/j.bbamcr.2008.01.024)
12. Coade SB, Pearson JD. 1989 Metabolism of adenine nucleotides in human blood. Circ. Res. 65, 531-537. (doi:10.1161/01.RES.65.3.531)
13. Forrester T. 1972 An estimate of adenosine triphosphate release into the venous effluent from exercising human forearm muscle. J. Physiol. 224, 611-628.
14. Beigi R, Kobatake E, Aizawa M, Dubyak GR. 1999 Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am. J. Physiol. Cell Physiol. 276, 267-278.
15. Hayashi S, Hazama A, Dutta AK, Sabirov RZ, Okada Y. 2004 Detecting ATP release by a biosensor method. Sci. STKE 2004, l14. (doi:10.1126/stke. 2582004pl14)
16. Buell G, Michel AD, Lewis C, Collo G, Humphrey PP, Surprenant A. 1996 P2X1 receptor activation in HL60 cells. Blood 87, 2659-2664.
17. Corriden R, Insel PA. 2010 Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci. Signal. 3, re1. (doi:10.1126/scisignal.3104re1)
18. Sabirov RZ, Dutta AK, Okada Y. 2001 Volumedependent ATP-conductive large-conductance anion channel as a pathway for swelling-induced ATP release. J. Gen. Physiol. 118, 251-266. (doi:10. 1085/jgp.118.3.251)
19. Schwiebert EM, Zsembery A. 2003 Extracellular ATP as a signaling molecule for epithelial cells. Biochim. Biophys. Acta 1615, 7-32. (doi:10.1016/S0005-2736(03)00210-4)
20. Reisin IL, Prat AG, Abraham EH, Amara JF, Gregory RJ, Ausiello DA, Cantiello HF. 1994 The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J. Biol. Chem. 269, 20 584-20 591.
21. Romanello M, Pani B, Bicego M, D'Andrea P. 2001 Mechanically induced ATP release from human osteoblastic cells. Biochem. Biophys. Res. Commun. 289, 1275-1281. (doi:10.1006/bbrc. 2001.6124)
22. Bodin P, Burnstock G. 2001 Purinergic signalling: ATP release. Neurochem. Res. 26, 959-969. (doi:10.1023/A:1012388618693)
23. D'hondt C et al. 2011 Pannexin channels in ATP release and beyond: an unexpected rendezvous at the endoplasmic reticulum. Cell Signal. 23, 305-316. (doi:10.1016/j.cellsig.2010.07.018)
24. Pellegatti P, Falzoni S, Pinton P, Rizzuto R, Di Virgilio F. 2005 A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 16, 3659-3665. (doi:10.1091/mbc.E05-03-0222)
25. Martins I et al. 2009 Chemotherapy induces ATP release from tumor cells. Cell Cycle 8, 3723-3728. (doi:10.4161/cc.8.22.10026)
26. Michaud M et al. 2011 Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334, 1573-1577. (doi:10.1126/science.1208347)
27. Llaudet E, Hatz S, Droniou M, Dale N. 2005 Microelectrode biosensor for real-time measurement of ATP in biological tissue. Anal. Chem. 77, 3267-3273. (doi:10.1021/ac048106q)
28. Nakamura M, Mie M, Funabashi H, Yamamoto K, Ando J, Kobatake E. 2006 Cell-surface-localized ATP detection with immobilized firefly luciferase. Anal. Biochem. 352, 61-67. (doi:10.1016/j.ab. 2006.02.019)
29. Schneider SW, Egan ME, Jena BP, Guggino WB, Oberleithner H, Geibel JP. 1999 Continuous detection of extracellular ATP on living cells by using atomic force microscopy. Proc. Natl Acad. Sci. USA 96, 12 180-12 185. (doi:10.1073/pnas.96. 21.12180).
30. Corriden R, Insel PA, Junger WG. 2007 A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells. Am. J. Physiol. Cell Physiol. 293, C1420-C1425. (doi:10.1152/ajpcell.00271.2007)
31. Wilson T, Hastings JW. 1998 Bioluminescence. Annu. Rev. Cell Dev. Biol. 14, 197-230. (doi:10.1146/ annurev.cellbio.14.1.197)
32. Contag CH, Bachmann MH. 2002 Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4, 235-260. (doi:10.1146/ annurev.bioeng.4.111901.093336)
33. Kim JB et al. 2010 Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS ONE 5, e9364. (doi:10.1371/journal.pone.0009364)
34. Selifonova O, Burlage R, Barkay T. 1993 Bioluminescent sensors for detection of bioavailable Hg(II) in the environment. Appl. Environ. Microbiol. 59, 3083-3090.
35. Hopkins TA, Seliger HH, White EH, Cass MW. 1967 The chemiluminescence of firefly luciferin. A model for the bioluminescent reaction and identification of the product excited state. J. Am. Chem. Soc. 89, 7148-7150. (doi:10.1021/ja01002a076)
36. Burnstock G. 2006 Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 27, 166-176. (doi:10.1016/j.tips.2006.01.005)
37. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F. 2008 Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE 3, e2599. (doi:10.1371/journal.pone.0002599)
38. Vial C, Owen P, Opie L, Posel D. 1987 Significance of release of adenosine triphosphate and adenosine induced by hypoxia or adrenaline in perfused rat heart. J. Mol. Cell Cardiol. 19, 187-197. (doi:10. 1016/S0022-2828(87)80561-8)
39. Gerasimovskaya EV, Ahmed S, White CW, Jones PL, Carpenter PC, Stenmark KR. 2002 Extracellular ATP is an autocrine/paracrine regulator of hypoxiainduced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the egr-1 transcription factor. J. Biol. Chem. 277, 44 638-44 650. (doi:10.1074/jbc. M203012200)
40. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP. 2002 Ecto-50-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993-1002.
41. Baricordi OR, Ferrari D, Melchiorri L, Chiozzi P, Hanau S, Chiari E, Rubini M, Di Virgilio F. 1996 An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87, 682-690.
42. Adinolfi E, Callegari MG, Ferrari D, Bolognesi C, Minelli M, Wieckowski MR, Pinton P, Rizzuto R, Di Virgilio F. 2005 Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol. Biol. Cell 16, 3260-3272. (doi:10.1091/mbc. E04-11-1025)
43. Di Virgilio F, Ferrari D, Adinolfi E. 2009 P2X(7): a growth-promoting receptor: implications for cancer. Purinergic Signal. 5, 251-256. (doi:10.1007/ s11302-009-9145-3)
44. la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G. 2001 Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J. Immunol. 166, 1611-1617.
45. Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, Eigler A. 2000 Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J. Immunol. 165, 4704-4709.
46. Di Virgilio F. 2012 Purines, purinergic receptors, and cancer. Cancer Res. 72, 5441-5447. (doi:10.1158/ 0008-5472.CAN-12-1600)
47. Ghiringhelli F et al. 2009 Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15, 1170-1178. (doi:10.1038/ nm.2028)
48. Wilhelm K et al. 2010 Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat. Med. 16, 1434-1438. (doi:10.1038/nm.2242)
49. Weber FC et al. 2010 Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J. Exp. Med. 207, 2609-2619. (doi:10.1084/jem.20092489)
50. Ayata CK et al. 2012 Purinergic P2Y(2) receptors promote neutrophil infiltration and hepatocyte death in mice with acute liver injury. Gastroenterology 143, 1620-1629. (doi:10.1053/j. gastro.2012.08.049)
51. Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Pelegrin P. 2012 P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J. 26, 2951-2962. (doi:10.1096/fj.12-205765)
52. Karimzadeh S, Moradi M, Hosseinkhani S. 2012 Delicate balance of electrostatic interactions and disulfide bridges in thermostability of firefly luciferase. Int. J. Biol. Macromol. 51, 837-844. (doi:10.1016/j.ijbiomac.2012.06.028)
53. Sung D, Kang H. 1998 The N-terminal amino acid sequences of the firefly luciferase are important for the stability of the enzyme. Photochem. Photobiol. 68, 749-753. (doi:10.1111/j.1751-1097.1998. tb02540.x)
54. Riahi-Madvar A, Hosseinkhani S, Rezaee F. 2013 Implication of Arg213 and Arg337 on the kinetic and structural stability of firefly luciferase. Int. J. Biol. Macromol. 52, 157-163. (doi:10.1016/j. ijbiomac.2012.09.007)
55. Fujii H, Noda K, Asami Y, Kuroda A, Sakata M, Tokida A. 2007 Increase in bioluminescence intensity of firefly luciferase using genetic modification. Anal. Biochem. 366, 131-136. (doi:10.1016/j.ab.2007.04.018)
56. Nakatsu T, Ichiyama S, Hiratake J, Saldanha A, Kobashi N, Sakata K, Kato H. 2006 Structural basis for the spectral difference in luciferase bioluminescence. Nature 440, 372-376. (doi:10. 1038/nature04542)
57. Woodroofe CC, Meisenheimer PL, Klaubert DH, Kovic Y, Rosenberg JC, Behney CE, Southworth TL, Branchini BR. 2012 Novel heterocyclic analogues of firefly luciferin. Biochemistry 51, 9807-9813. (doi:10.1021/bi301411d)